|Bid||5.20 x 1400|
|Ask||4.91 x 900|
|Day's Range||4.62 - 5.39|
|52 Week Range||1.45 - 11.30|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 14, 2022 - Nov 18, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.00|
Terns Pharmaceuticals, Napco Security Technologies and AVEO have been highlighted in this Screen of The Week article.
FOSTER CITY, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that management will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14 at 2:00 p.m. ET. A live audio
A look at the shareholders of Terns Pharmaceuticals, Inc. ( NASDAQ:TERN ) can tell us which group is most powerful...